381 related articles for article (PubMed ID: 23444015)
1. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
[TBL] [Abstract][Full Text] [Related]
2. Investigating metabotropic glutamate receptor 5 allosteric modulator cooperativity, affinity, and agonism: enriching structure-function studies and structure-activity relationships.
Gregory KJ; Noetzel MJ; Rook JM; Vinson PN; Stauffer SR; Rodriguez AL; Emmitte KA; Zhou Y; Chun AC; Felts AS; Chauder BA; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2012 Nov; 82(5):860-75. PubMed ID: 22863693
[TBL] [Abstract][Full Text] [Related]
3. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
[TBL] [Abstract][Full Text] [Related]
4. Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators.
Lundström L; Bissantz C; Beck J; Wettstein JG; Woltering TJ; Wichmann J; Gatti S
Br J Pharmacol; 2011 Sep; 164(2b):521-37. PubMed ID: 21470207
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
[TBL] [Abstract][Full Text] [Related]
6. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
[TBL] [Abstract][Full Text] [Related]
7. Differential Pharmacology and Binding of mGlu
O'Brien DE; Shaw DM; Cho HP; Cross AJ; Wesolowski SS; Felts AS; Bergare J; Elmore CS; Lindsley CW; Niswender CM; Conn PJ
Mol Pharmacol; 2018 May; 93(5):526-540. PubMed ID: 29545267
[TBL] [Abstract][Full Text] [Related]
8. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding.
Butkiewicz M; Rodriguez AL; Rainey SE; Wieting J; Luscombe VB; Stauffer SR; Lindsley CW; Conn PJ; Meiler J
ACS Chem Neurosci; 2019 Aug; 10(8):3427-3436. PubMed ID: 31132237
[TBL] [Abstract][Full Text] [Related]
10. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
[TBL] [Abstract][Full Text] [Related]
11. Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology.
Muraleetharan A; Wang Y; Rowe MC; Gould A; Gregory KJ; Hellyer SD
Mol Pharmacol; 2023 Jun; 103(6):325-338. PubMed ID: 36921922
[TBL] [Abstract][Full Text] [Related]
12. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
[TBL] [Abstract][Full Text] [Related]
13. Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.
Gregory KJ; Nguyen ED; Malosh C; Mendenhall JL; Zic JZ; Bates BS; Noetzel MJ; Squire EF; Turner EM; Rook JM; Emmitte KA; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
ACS Chem Neurosci; 2014 Apr; 5(4):282-95. PubMed ID: 24528109
[TBL] [Abstract][Full Text] [Related]
14. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
[TBL] [Abstract][Full Text] [Related]
15. Development of allosteric modulators of GPCRs for treatment of CNS disorders.
Nickols HH; Conn PJ
Neurobiol Dis; 2014 Jan; 61():55-71. PubMed ID: 24076101
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.
Sengmany K; Hellyer SD; Albold S; Wang T; Conn PJ; May LT; Christopoulos A; Leach K; Gregory KJ
Neuropharmacology; 2019 May; 149():83-96. PubMed ID: 30763654
[TBL] [Abstract][Full Text] [Related]
17. Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
Pérez-Benito L; Doornbos MLJ; Cordomí A; Peeters L; Lavreysen H; Pardo L; Tresadern G
Structure; 2017 Jul; 25(7):1153-1162.e4. PubMed ID: 28648611
[TBL] [Abstract][Full Text] [Related]
18. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
[TBL] [Abstract][Full Text] [Related]
19. Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system function.
Noetzel MJ; Rook JM; Vinson PN; Cho HP; Days E; Zhou Y; Rodriguez AL; Lavreysen H; Stauffer SR; Niswender CM; Xiang Z; Daniels JS; Jones CK; Lindsley CW; Weaver CD; Conn PJ
Mol Pharmacol; 2012 Feb; 81(2):120-33. PubMed ID: 22021324
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis reveals multiple mechanisms of allosteric modulation of the mGlu5 receptor in rat astroglia.
Bradley SJ; Langmead CJ; Watson JM; Challiss RA
Mol Pharmacol; 2011 May; 79(5):874-85. PubMed ID: 21321061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
